Boosted influenza-specific T cell responses after H5N1 pandemic live attenuated influenza virus (pLAIV) vaccination
Background: In a phase I clinical trial, a H5N1 pandemic live attenuated influenza virus (pLAIV) VN2004 vaccine bearing avian influenza H5N1 HA and NA genes on the A/Ann Arbor cold-adapted vaccine backbone displayed very restricted replication. We evaluated T cell responses to H5N1 pLAIV vaccination...
Main Authors: | Yanchun ePeng, Beibei eWang, Kawsar eTalaat, Ruth eKarron, Timothy J Powell, Hui eZeng, Danning eDong, Catherine J Luke, Andrew eMcMichael, Kanta eSubbarao, Tao eDong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00287/full |
Similar Items
-
Seed shattering: from models to crops
by: Yang eDong, et al.
Published: (2015-06-01) -
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
by: Sreeja Roy, et al.
Published: (2020-11-01) -
Re-engaging cross-reactive memory B Cells: The influenza puzzle
by: Ali H. eEllebedy, et al.
Published: (2012-03-01) -
Impacts of temperature and pH on the distribution of archaeal lipids in Yunnan hot springs, China
by: Weiyan eWu, et al.
Published: (2013-10-01) -
Verification of the cross immunoreactivity of A60, a mouse monoclonal antibody against neuronal nuclear protein
by: Shanping eMao, et al.
Published: (2016-05-01)